




© Authors; 2021.  (CC BY-NC-SA 4.0) 
This is an Open Access article which permits unrestricted 
non-commercial use, provided the original work is properly cited. 
International Journal of Cyrrent Reseach in Physiology and Pharmacology
Vol 5, Issue 2, 2021.
Sumathi Publications 
Original  Article
Evidence supporting the use of Combretum 
nigricans as an antimalarial agent in 
Ethnomedicine
Enegide Chinedu1,2, Akah Peter A2, Ofili Charles C3, Agatemor Uzuazokaro M1, Ameh Solomon F4, 
Jacob Dabum L5, Onah Ifeoma A6
1Department of Pharmacology, Novena University, Ogume, Delta State, Nigeria 
2Department of Pharmacology & Toxicology, Faculty of Pharmaceutical Sciences, University of Nigeria, 
Nsukka, Nigeria 
3Department of Public and Community Health, Novena University, Ogume, Delta State, Nigeria 
4Department of Pharmacology & Toxicology, National Institute for Pharmaceutical Research and 
Development, Idu, Abuja, Nigeria 
5Department of Human Physiology, Faculty of Medical Sciences, University of Jos, Jos, Nigeria 
6Department of Pharmaceutical Microbiology & Biotechnology, Faculty of Pharmaceutical Sciences, University of 
Nigeria, Nsukka, Nigeria
AbstrAct 
Background: Combretum nigricans (Combretaceae) is a small, smooth bark tree used in traditional medicine to treat 
prurigo, dysentery, fever, and other symptoms of acute malaria in North-Central Nigeria. Methods: The antimalarial 
activity of C. nigricans hydro-methanol crude leaf extract was evaluated against Plasmodium berghei in mice. The 
Peters’ 4-day suppressive test against early malaria infection and Rane’s curative test against established malaria were 
employed in assessing the antimalarial activity of the crude extract. In each test model, five groups containing five mice 
each were used. Group 1 mice were administered with 10 ml distilled water/kg b.w. p.o., groups 2 - 4 were administered 
with 200, 400, and 800 mg extract/kg b.w. p.o. respectively, while group 5 mice were administered with artesunate 
10 mg/kg b.w. p.o. Result: All doses of C. nigricans extract employed for the study (200 – 800 mg/kg b.w. p.o.) gave 
significant (P<0.05) chemosuppressive effect against P. berghei, this effect was observed to be dose-related; while the 
400 mg/kg extract dose gave the highest curative effect. Compared to control, the extract also prolonged the mean 
survival time at all doses and as well prevented the characteristic decrease in body temperature elicited by P. berghei in 
mice. The LD50 of the extract was >5000 mg/kg b.w. p.o. in mice. Conclusion: The result from the study indicates that 
C. nigicans crude leaf extract is safe orally and possesses significant antimalarial activity.
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IntroductIon
Malaria remains a significant public health problem (especially in most developing countries), with about 250 million new 
cases and over 600,000 mortalities annually.
[1 – 4] About 40% of the world’s population is 
currently at risk of being infected with malaria.
[5] Africa, however, accounts for most of the
global malaria cases (about 88%) and mortality
(about 90%). Most of the recorded severe cases
and mortalities in the sub-Saharan African 
region occur in pregnant women and children 
less than 5 years of age.[6] Though several 
agents are currently available for treatment 
and prophylaxis against malaria, it is still one 
of the most significant global health threats, 
maintaining its ranking among the top five 
causes of mortality among children less than 
5 years of age. This can be primarily attributed 
to the increasing malaria parasite resistance 
to currently available antimalarial agents, 
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including quinine, mefloquine, chloroquine, 
atovaquone, and sulfadoxine/pyrimethamine.[7 
- 10] This challenge has necessitated the need to
develop new antimalarial agents.
Medical chronicles have shown that plants 
are a vital source for developing new drugs, 
including antimalarials.[11, 12] As a matter of 
fact, some of the currently used antimalarial 
agents were derived from plant sources; these 
include the premiere antimalarial agent, quinine 
(derived from the stem-bark of cinchona plant), 
and the current standard antimalarial drug, 
artemisinin (derived from Artemisia annua).
[13] These successes, coupled with the fact
that several other plants are currently being
used traditionally in various parts of the
world to manage malaria, have actuated more
research into medicinal plants to develop new
antimalarial agents. About 80% of the African
population still depends on herbs to manage
several ailments, including malaria.[14, 15]
Combretum nigricans is one such plant; it is
a small tree with smooth bark found in North-
Central Nigeria and is traditionally used to
treat malaria fever. The seed has been reported
to possess hypotensive and central nervous
system depressant activities,[16] while the anti-
leishmaniasis activity has also been reported.
[17] The plant has also been reported to possess
antifungal activity [16] as well as cytotoxic effect.
[18] In this light, the aim of this study was to
evaluate the antimalarial activity of C. nigricans
crude extract in mice and hence seek if there
is a scientific justification for its traditional
application for the management of malaria.
MaterIal and Methodology 
Plant materials: Fresh leaves of Combretum 
nigricans were collected from Jos-North Local 
Government Area, Plateau State, Nigeria. It was 
identified and authenticated by Mr. Jeffrey Azila, 
a taxonomist at the Federal College of Forestry, 
Jos, Plateau State, Nigeria. In addition, a voucher 
specimen (FHJ223) was prepared and deposited 
at the Federal College of Forestry herbarium for 
future reference. 
Extraction: The leaf samples were rinsed, air-
dried (for two weeks), and pulverized into a fine 
powder using a plant milling machine. Using 
standard procedure as illustrated by Handa 
et al.,[19], the pulverized leaves (1.6 kg) were 
macerated in methanol-water (1:1) v/v for 48 
h with intermittent vigorous shaking. After 48 
h, the mixture was filtered using muslin cloth 
followed by Whatman filter paper (No.1). The 
obtained crude extract was concentrated and 
stored at 4°C in a refrigerator till use.
Phytochemical analysis: The crude extract 
was subjected to phytochemical analysis for 
constituent identification using standard 
procedures illustrated by Harborne 20] and 
Evans [21] to test for the presence of alkaloids, 
saponin, glycosides, carbohydrates, flavonoids, 
tannins, terpenoids, resins, proteins, reducing 
sugar, quinines, and steroids.
Animals: Swiss albino mice of both sexes 
(weighing 22±1.08 g) housed at the animal 
facility of the Department of Pharmacology and 
Toxicology, University of Nigeria, Nsukka, were 
used. The animals were housed in standard 
cages under standard laboratory conditions at 
room temperature, and humidity with a 12-h 
light/dark cycle and ad libitum access to mice 
feed and water. All animal experiments were 
conducted following the NIH guidelines for 
laboratory animal care and use (Revised 1985) 
[22] and the University of Nigeria regulations for
laboratory animal use.
Acute toxicity test (LD50): The C. nigricans 
crude extract’s acute oral toxicity was carried 
out on Swiss albino mice using Lorke’s method.
[23] A total of 12 mice of either sex were fasted
overnight before the study. The study involved
two phases.  In the first phase, nine mice were
randomly divided into three groups of three mice
each and were administered the extract doses
of 10, 100, and 1000 mg/kg body weight orally,
respectively.  They were observed critically for
the first 4 h after dosing and subsequently for
24 h for signs of toxicity and mortality. In the
second phase, three fresh mice were divided
into three groups, one per group, and were
administered extract doses of 1600, 2900, and
5000 mg/kg body weight, respectively. The
animals were observed for signs of toxicity and
mortality for the first 4 h and subsequently for
24 h. They were further observed for 2 weeks for
delayed toxicity. The LD50 (acute toxicity dose)
was calculated using the following formula:
LD50 = √(highest non-lethal dose × least lethal 
dose) 
Rodent parasite [Plasmodium berghei (NK-
65)]: The rodent parasite was sourced from the 
Faculty of Veterinary Medicine, University of 
Nigeria, Nsukka, and maintained alive in mice 
by the serial intraperitoneal passage of blood 
from donor mouse to another mouse. The re-
infected mice were kept at the University of 
Nigeria, Department of Pharmacology and 
Toxicology animal house unit, where the study 
was conducted.
In vivo antimalarial studies 
Parasite inoculation: Standard inoculum 
consisting of about 1 × 107 of Plasmodium 
berghei (NK-65) parasitized erythrocytes per ml 
from donor mouse in 0.2 ml normal saline was 
made. Each experimental mouse was inoculated 
intraperitoneally with 0.2 ml of infected blood 
suspension containing Plasmodium berghei NK-
65 parasitized erythrocytes.
Activity on early malaria infection (suppressive 
test): The Peters’ 4-day suppressive test against 
Plasmodium berghei (NK-65) infection in mice 
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was employed to test for the suppressive activity 
of the crude extract.[24]  On the first day (D0), 
twenty-five Swiss albino mice of both sex were 
inoculated intraperitoneally (IP) with 0.2 ml of 
standard inoculum of parasitized erythrocyte as 
described above. The mice were divided into 5 
groups of 5 mice each (i.e., 5 mice per group) 
and treated for 4 consecutive days (D0 - D3). 
Group I mice (control) were administered 10 ml 
distilled water/kg body weight daily. Groups 2, 
3, and 4 were administered with 200, 400, and 
800 mg extract/kg body daily, respectively. The 
administration was done orally using an intra-
gastric cannula. Group 5 mice were treated with 
artesunate 10 mg/kg body weight daily. On the 
5th day of study (D4), blood from the tail of each 
mouse was smeared on a microscope slide to 
make a thin film. The films were stained with 
Giemsa stain and examined under a microscope 
as illustrated by Huang et al.,[25]  to determine 
parasitaemia and percentage suppression.
Percentage suppression = (A – B/A) × 100
Where; A = mean parasitaemia in the negative 
control group; B = mean parasitaemia in the 
test/standard group.
Activity on established malaria infection 
(Rane test)
The curative activity of C. nigricans crude extract 
against established malaria infection was 
evaluated following the procedure outlined by 
Ryley and Peters.[26] Twenty-five Swiss albino 
mice of both sexes were weighed and grouped 
into five groups of five mice each. The animals 
were inoculated intraperitoneally (IP) on the first 
day (D0) with 0.2 ml of standard inoculum of 
parasitized erythrocyte and left untreated until 
the fourth day (D3) of study. On the fourth day 
(D3), blood from the tail of each mouse was 
smeared on a microscope slide to make a thin 
film. The blood films were stained with Giemsa 
stain and examined under a light microscope 
to determine pre-treatment parasitemia. The 
animals were treated for four days (D3 - D6). 
Group I mice (control) were administered with 
10 ml distilled water/kg body weight per oral. 
Groups 2 - 4 mice were administered with 
200, 400, and 800 mg extract/kg body weight 
orally. At the same time, Group 5 mice were 
administered with artesunate 10 mg/kg body 
weight orally. Blood was collected from each 
mouse by tail bleeding on D7, and thin blood 
film was made on a microscope slide. The films 
were stained and examined under a microscope 
as described previously to determine post-
treatment parasitemia level. The percentage 
parasite clearance was calculated using the 
following formula:
Parasite clearance (%) = (X – Y/X) × 100
Where; X = pre-treatment (D3) mean parasitaemia 
Y= post-treatment (D7) mean parasitaemia 
Mean survival time: The animals were 
monitored to ascertain the mean survival time 
(days) across each group. The mice in each 
group were monitored daily for mortality from 
the first day of infection (D0); this was continued 
after the treatment period till mortality of all the 
animals. The mean survival time was recorded 
for each group as described by Saidu et al.[25]
Temperature determination: The rectal 
temperature of each mouse in all groups was 
taken before infection (D0), during treatment (D3 
- D6), and after treatment (D7). The temperature
was taken using a digital thermometer. The
change in rectal temperature of treated groups
was compared with the control group.
Statistical analysis
The data obtained were expressed as the mean, 
standard error of the mean (Mean ± SEM). One-
way analysis of variance (ANOVA) followed by 
Dunnet’s post hoc test was used to test for 
significance. P<0.05 was considered significant. 
GraphPad Prism for windows (version 7.0), San 
Diego California, USA was used for the analysis.
results
Phytochemical screening
The results obtained from the phytochemical 
screening of C. nigricans crude leaf extract 
revealed the presence of alkaloids, cardiac 
glycosides, terpenoids, saponins, flavonoids, 
quinines, steroids, carbohydrate, taninins, 
proteins, and reducing sugar; while resins were 
absent.
Acute toxicity (LD50)
The mice appeared normal, and no mortality was 
recorded at all the doses used for the study after 
24 h, and throughout the two weeks observation 
period for delayed toxicity [Table 1]. The oral 
median lethal dose (LD50) of C. nigricans in mice 
was estimated to be greater than 5000 mg/kg 
body weight. 
Table 1. Oral acute toxicity of Combretum nigricans crude 
leaf extract











Phase 1 10 0/3 0/3
100 0/3 0/3
1000 0/3 0/3
Phase 2 1600 0/1 0/1
2900 0/1 0/1
5000 0/1 0/1
Activity on early malaria infection (suppressive 
test)
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All doses of C. nigricans crude leaf extract gave 
significant (P<0.05) chemosuppressive effect 
against P. berghei, this effect was observed to 
be dose-related [Table 2]. The percent chemo 
suppression were 49.1, 57.5 and 75.5% for 200, 
400 and 800 mg/kg doses respectively, while 
artesunate gave 78.3% [Figure 1].
Table 2. Chemosuppressive activity of C. nigricans crude 
leaf extract in P. berghei infected mice
Treatment Dose (mg/kg) Mean parasite 
count
 Control 10 ml/kg 21.2 ± 0.80
C. nigricans 200 10.8 ± 1.02*
400 9.0 ± 1.10*
800 5.2 ± 0.37*
Artesunate 10 4.6 ± 0.24*
Values expressed as Mean ± SEM, where n=5, 
*significant at P<0.05
Figure 1. Percent chemosuppressive activity of C. 
nigricans crude extract against P. berghei in mice. Art 
= artesunate, CNCE= Combretum nigricans crude leaf 
extract.
Activity on the established infection (Rane 
test)
The crude extract exhibited a significant (P<0.05) 
curative effect in established infection [Table 3]. 
The erythrocyte parasite clearance was 41.3%, 
69.4%, and 64.8% for 200, 400, and 800 mg/kg, 
respectively, while artesunate gave 69.2%. No 
parasite clearance was observed in the control 
group, but rather there was an increase by 
28.2% [Figure 2].
Table 3. Curative activity of C. nigricans crude leaf extract 




Day 3 Day 7
Control 10 ml/kg 28± 1.3 35.9±1.78
C. . 
nigricans
200 25.2±0.6 14.8± 1.9*
400 26.8± 1.7 8.2± 1.07*
800 26.4±1.2 9.3± 0.3*
Artesunate 10 26±3.5 8± 0.58*
Values expressed as Mean ± SEM, where n=5, *significant 
at P<0.05
Figure 2. Erythrocyte clearance of P. berghei by C. 
nigricans crude leaf extract in mice. Art = artesunate, 
CNCE= Combretum nigricans crude leaf extract.
There was a progressive decrease in mice body 
temperature of the control from study D3 through 
D7. This observed decrease in body temperature 
was as low as 32.6 0C on D7. C. nigricans 
extract substantially prevented the decrease of 
temperature in a dose-related manner, with C. 
Figure 3. Effect of C. nigricans crude leaf extract on the body temperature of mice infected with P. berghei 
(curative test). Art = artesunate, CNCE= Combretum nigricans crude leaf extract.
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nigricans 800 mg/kg dose giving the highest 
effect. The standard drug artesunate also had 
the same effect of preventing body temperature 
decrease [Figure 3].
There was a prolongation in the mean survival 
time of the extract-treated groups, and the 
artesunate treated group compared to the 
control. This effect was also dose-dependent and 
was significant (P<0.05) in all the treated groups 
except the group treated with  200 mg extract/kg, 
in which the effect was not significant (P<0.05). 
The mean survival time of the control group was 
11.0 days, while that of the groups administered 
crude extract were 13.5, 16.0, and 18.5 days 
for 200, 400, and 800 mg/kg, respectively. The 
group administered artesunate had the longest 
survival time, 21.3 days [Figure 4].
Figure 4. Effect of C. nigricans on the mean survival times 
of mice infected with P. berghei in curative test. Art = 
artesunate, CNCE = Combretum nigricans crude extract.
dIscussIon
In this study, the in vivo antimalarial activity 
of Combretum nigricans, a plant used in 
traditional medicine in North-Central Nigeria, 
was evaluated on Plasmodium berghei infected 
mice using the suppressive and curative in vivo 
models. In vivo models were employed for this 
study because it considers possible pro-drug 
effect and possible involvement of immune 
system in the extermination of the infection.[27, 
12] Rodent Malaria models (especially P. berghei)
are known to elicit disease features similar to
those of human Plasmodial infection,[28 -
30] hence are used in preclinical research to
predict possible clinical outcomes of prospective
antimalarial agents. The rodent malaria model
identified several important antimalarial agents
such as chloroquine, halofantrine, mefloquine,
and artemisinin.[31] These facts, therefore,
justify its application for the study.
The Peters’ 4-day suppressive test on early 
malaria infection and Rane’s curative test on 
established malaria infection is commonly 
employed for screening antimalarial agents. In 
both methods, the reduction of parasitemia in 
the treated group to a level ≤ 90% of the control 
(untreated) group indicates a potent antimalarial 
activity by the test agent.[32] 
The result obtained from the study showed that 
all doses of the crude extract demonstrated 
significant (P<0.05) antimalarial activity in 
both test models. The extract gave a significant 
(P<0.05) chemosuppressive effect against 
P. berghei in a dose-related fashion in the
suppressive study. The highest chemosupressive
activity by the extract (75.5% chemosuppression)
was observed in the group treated with 800 mg/
kg (highest test dose). This effect was closely
related to that elicited by artesunate (78.3%
chemosuppression), the standard antimalarial
drug used for the study.
The extract also demonstrated significant 
(P<0.05) erythrocyte clearance of the 
Plasmodium parasite in the curative study. 
The highest extract activity was observed in 
the administered 400 mg extract/kg (69.4%); 
however, this was relatively close to the parasite 
clearance elicited by the highest test dose, 800 
mg/kg (64.8%). This may serve as an indication 
that C. nigricans crude extract 400 mg/kg 
may be the best therapeutic dose in mice. The 
control group showed a significant decrease in 
body temperature, which progressed till D7, 
this decrease in body temperature was less 
in the extract-treated groups and artesunate 
group. Though fever (pyrexia) is one of the major 
manifestations of malaria in humans [33], it is 
different in the rodent model of malaria, which 
is usually characterized by hypothermia rather 
than pyrexia.[34] Previous studies have shown 
that the body temperature of mice infected 
with P. berghei will progressively decrease 
significantly from the fourth day of infection 
if left untreated. [35, 36] This sustained 
hypothermia in P. berghei infected mice may be 
attributed to the general debilitating effects of 
malaria on the host, resulting in excessive body 
heat loss and ultimately leading to death.[36] 
The treatment of P. berghei infected mice with 
a potent antimalarial agent will prevent this 
phenomenon (i.e., hypothermia); this is because 
the body temperature of P. berghei infected mice 
usually decreases as the parasite level increases; 
hence agents that prevent parasite increase will 
also prevent the significant decrease of body 
temperature. Hence the effect of the extract on 
the body temperature of the treated mice can be 
attributed to its antiplasmodial activity, while the 
substantial decrease in the body temperature of 
the control group, which progressed till the eight-
day (D7), maybe due to a progressive increase in 
the erythrocyte parasite level. The extract also 
prolonged the mean survival time in the curative 
test. This effect was significant in groups 
treated with extract doses of 400 and 800 mg/
kg, which had a mean survival time of 16.0 and 
18.5 days, respectively. Mean survival time is a 
useful parameter for evaluating the antimalarial 
efficacy of potential antimalarial agents.[37] 
A candidate antimalarial agent is considered 
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potent if the mice in the treatment group survive 
for more than 12 days after infection. These 
observations have demonstrated that the C. 
nigricans crude extract is a potent antimalarial 
agent; however, the therapeutic effects of 
plant extracts are known to be elicited by the 
bioactive chemicals (phytochemicals) present 
in them. Hence, the extract’s antimalarial 
activity may also be due to the phytochemicals 
present in it. The phytochemical assessment 
results revealed the presence of several 
important phytochemicals in the extract whose 
antimalarial activities have been documented. 
Among them are terpenoids, alkaloids, saponins, 
and flavonoids.[38 - 41]  Terpenoids are known 
to possess oxidant generating potential, which 
elicits antiplasmodial and cytotoxic effects. The 
cytotoxic effect of pentacyclic triterpenes (a 
class of terpenoids) isolated from C. nigricans 
has previously been reported by Simon et 
al.[44] Similarly, the antiplasmodial activity 
of triterpenes isolated from the methanolic 
leaf extract of Combretum racemosum (a plant 
from the Combretum genus also) has also 
been reported.[45] The mechanism of action of 
artemisinin (a terpenoid isolated from Atermesia 
annua) and its derivatives (including artesunate) 
against Plasmodium parasites is based on their 
oxidant producing activity and has also been 
reported to possess cytotoxic activity against 
invasive breast ductal carcinoma.[46] This 
evidence suggests that terpenoids present in C. 
nigricans are the culprit antiplasmodial principle 
in the plant and may elicit their antiplasmodial 
effect through oxidant producing mechanism. 
Aside from antiplasmodial activity elicited by 
terpenoids, other bioactive components such as 
flavonoids, alkaloids, and saponins present in 
the extract may have also elicited complementary 
antiplasmodial effects.[39, 40, 47] [42, 43]
The acute toxicity test result showed that the oral 
median lethal dose of C. nigricans crude extract 
was more remarkable than 5000 mg/kg in mice. 
According to previous studies, therapeutic agents 
with oral acute toxicity values greater than 5000 
mg/kg are considered safe or practically non-
toxic.[48, 49] This therefore, indicates that the 
extract also has a wide therapeutic window in 
mice coupled with its antimalarial potency.
conclusIon
The result from the study indicates that C. 
nigicans crude leaf extract possesses significant 
antimalarial activity, which may serve as a 
scientific justification for its application as an 
antimalarial agent ethnomedicine.
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